# OnCo record ret (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/ret/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "ret" ;
  schema:name "RET"@en ;
  schema:description "RET is a kinase altered in thyroid cancer and a small slice of lung cancer, treatable with one selective pill regardless of where the tumour is."@en ;
  schema:url <https://onco.cc/targets/ret/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/RET_proto-oncogene>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:9967>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165731>, <https://www.uniprot.org/uniprotkb/P07949/entry>, <https://www.ncbi.nlm.nih.gov/gene/5979> ;
  owl:sameAs <http://www.wikidata.org/entity/Q415976> ;
  schema:citation <https://en.wikipedia.org/wiki/RET_proto-oncogene> ;
  onco:tag "driver", "kinase" ;
  schema:alternateName "RET" ;
  onco:targetClass "kinase" ;
  onco:firstDescribed "1987"^^xsd:gYear ;
  onco:related <https://onco.cc/biomarkers/ret-fusion/> ;
  onco:cancers <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/guardant360-cdx/>, <https://onco.cc/drugs/oncomine-dx-target-test/>, <https://onco.cc/drugs/al2846/>, <https://onco.cc/drugs/ep0031/> ;
  onco:companies <https://onco.cc/companies/imagene-ai/>, <https://onco.cc/companies/lucence/> ;
  onco:pathways <https://onco.cc/pathways/ras-mapk/>, <https://onco.cc/pathways/nsclc-signalling/>, <https://onco.cc/pathways/thyroid-cancer-signalling/> ;
  onco:terms <https://onco.cc/terms/gene-fusion/>, <https://onco.cc/terms/tumour-agnostic/> ;
  onco:trials <https://onco.cc/trials/nct06147570/> .